104 related articles for article (PubMed ID: 9680136)
1. Encapsidation studies of poliovirus subgenomic replicons.
Barclay W; Li Q; Hutchinson G; Moon D; Richardson A; Percy N; Almond JW; Evans DJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1725-34. PubMed ID: 9680136
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase.
Porter DC; Ansardi DC; Wang J; McPherson S; Moldoveanu Z; Morrow CD
Virology; 1998 Mar; 243(1):1-11. PubMed ID: 9527910
[TBL] [Abstract][Full Text] [Related]
3. Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation.
Johansen LK; Morrow CD
J Virol; 2000 Sep; 74(18):8335-42. PubMed ID: 10954532
[TBL] [Abstract][Full Text] [Related]
4. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
Porter DC; Ansardi DC; Morrow CD
J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
[TBL] [Abstract][Full Text] [Related]
5. trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins.
Jia XY; Van Eden M; Busch MG; Ehrenfeld E; Summers DF
J Virol; 1998 Oct; 72(10):7972-7. PubMed ID: 9733835
[TBL] [Abstract][Full Text] [Related]
6. A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA.
Percy N; Barclay WS; Sullivan M; Almond JW
J Virol; 1992 Aug; 66(8):5040-6. PubMed ID: 1321286
[TBL] [Abstract][Full Text] [Related]
7. Functional coupling between replication and packaging of poliovirus replicon RNA.
Nugent CI; Johnson KL; Sarnow P; Kirkegaard K
J Virol; 1999 Jan; 73(1):427-35. PubMed ID: 9847348
[TBL] [Abstract][Full Text] [Related]
8. The RNA encompassing the internal ribosome entry site in the poliovirus 5' nontranslated region enhances the encapsidation of genomic RNA.
Johansen LK; Morrow CD
Virology; 2000 Aug; 273(2):391-9. PubMed ID: 10915610
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin-2.
Basak S; McPherson S; Kang S; Collawn JF; Morrow CD
J Interferon Cytokine Res; 1998 May; 18(5):305-13. PubMed ID: 9620357
[TBL] [Abstract][Full Text] [Related]
10. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins.
Moldoveanu Z; Porter DC; Lu A; McPherson S; Morrow CD
Vaccine; 1995 Aug; 13(11):1013-22. PubMed ID: 8525684
[TBL] [Abstract][Full Text] [Related]
11. Targeted foreign gene expression in spinal cord neurons using poliovirus replicons.
Bledsoe AW; Gillespie GY; Morrow CD
J Neurovirol; 2000 Apr; 6(2):95-105. PubMed ID: 10822323
[TBL] [Abstract][Full Text] [Related]
12. Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.
Ansardi DC; Pal-Ghosh R; Porter D; Morrow CD
J Virol; 1995 Feb; 69(2):1359-66. PubMed ID: 7815522
[TBL] [Abstract][Full Text] [Related]
13. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of poliovirus subgenomic replicons.
Kaplan G; Racaniello VR
J Virol; 1988 May; 62(5):1687-96. PubMed ID: 2833619
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
Ansardi DC; Luo M; Morrow CD
Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
[TBL] [Abstract][Full Text] [Related]
16. Characterization of poliovirus replicons encoding carcinoembryonic antigen.
Ansardi DC; Moldoveanu Z; Porter DC; Walker DE; Conry RM; LoBuglio AF; McPherson S; Morrow CD
Cancer Res; 1994 Dec; 54(24):6359-64. PubMed ID: 7527296
[TBL] [Abstract][Full Text] [Related]
17. Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV(smm) PBj14.
Anderson MJ; Porter DC; Fultz PN; Morrow CD
Virology; 1996 May; 219(1):140-9. PubMed ID: 8623523
[TBL] [Abstract][Full Text] [Related]
18. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.
Porter DC; Melsen LR; Compans RW; Morrow CD
J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700
[TBL] [Abstract][Full Text] [Related]
19. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.
Porter DC; Ansardi DC; Choi WS; Morrow CD
J Virol; 1993 Jul; 67(7):3712-9. PubMed ID: 8389902
[TBL] [Abstract][Full Text] [Related]
20. In vitro construction of poliovirus defective interfering particles.
Hagino-Yamagishi K; Nomoto A
J Virol; 1989 Dec; 63(12):5386-92. PubMed ID: 2555563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
